Meet Some of the Physicians
and Cervical Spinal Cord
Injury Patients in the
AST-OPC1 Clinical Trial
 

SEC Filings



Date Filed Type Description Filer View
September 27, 20133Initial filing by director officer or owner of more than ten percent.LEBKOWSKI JANE
September 27, 20133Initial filing by director officer or owner of more than ten percent.SPINK KATHARINE E.
September 27, 20133Initial filing by director officer or owner of more than ten percent.VON ESCHENBACH
September 27, 20133Initial filing by director officer or owner of more than ten percent.BERGER FRANKLIN M
September 27, 20133Initial filing by director officer or owner of more than ten percent.WEST MICHAEL D
September 27, 20133Initial filing by director officer or owner of more than ten percent.BIOTIME INC
September 24, 20138-A12GRegistration of certain classes of securities 12(g) of the Securities Exchange Act 
September 24, 2013S-1/AAmended Registration statement for face-amount certificate companies 
September 03, 2013S-1/AAmended Registration statement for face-amount certificate companies 
August 13, 2013S-1/AAmended Registration statement for face-amount certificate companies 
June 26, 2013S-1/AAmended Registration statement for face-amount certificate companies 
April 03, 2013S-1Registration statement for face-amount certificate companies 
<< first | prev | next | last >>
page (14 of 14)
Asterias Biotherapeutics Tel: (510) 456-3800